Dr. Ryan Daryl Melvin, DO

Dr. Melvin practices at Cardiovascular Surgical Institute of Northwest Florida in Panama City, Florida.

Dr. Melvin's NPI, 1679919724, was assigned on May 16, 2013. Dr. Melvin graduated from Michigan State University College Of Osteopathic Medicine in 2013. Dr. Melvin holds Florida license OS17630.

Dr. Melvin's primary practice is Cardiovascular Surgical Institute of Northwest Florida, at 625 W Baldwin Road Suite D, Panama City, FL 32405. The practice phone is (850) 820-7900.

Dr. Melvin's primary practice is Cardiovascular Surgical Institute of Northwest Florida in Panama City, Florida. Dr. Melvin is also affiliated with HCA Florida Gulf Coast Hospital. The medical group on file is Cardiovascular Institute of Northwest Florida. Dmand AI also links Dr. Melvin to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Melvin's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Melvin practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Melvin's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Melvin is board certified in cardiology by the AOA Board of Internal Medicine. Dr. Melvin is licensed in Florida.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic hypertension, coronary artery disease, heart blockage and heart failure among the conditions Dr. Melvin treats.

CMS data shows 312 Medicare services from Dr. Melvin across 6 procedure codes in 2024, for 219 Medicare patients. Medicare paid $7,387 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 219 Medicare patients who saw Dr. Melvin in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Melvin's median patient age at 72, with 44% women.

In 2024, Dr. Melvin wrote 1,182 Medicare Part D claims for 342 patients. 82% of them were for generic drugs. CMS names the drug for 1,077 of them, across 25 drugs with 11 or more claims each, at $217,044 in total drug cost. In 2023, CMS named 3,770 claims across 39 drugs.

Dr. Melvin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 269 general payments to Dr. Melvin from 27 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 89% of the total. CSL Behring paid the most, $53,667.

Dr. Melvin graduated from Michigan State University College Of Osteopathic Medicine in 2013.

Dr. Melvin is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.